sprite-preloader
Anzeige
Mehr »
Dienstag, 21.11.2017 Börsentäglich über 12.000 News von 570 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A2DHL5 ISIN: US29414D1000 Ticker-Symbol: N16 
Aktie:
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
ENVISION HEALTHCARE CORPORATION Chart 1 Jahr
1-Woche-Intraday-Chart
ENVISION HEALTHCARE CORPORATION 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
24,64
24,79
20.11.
16.09.2017 | 05:09
(4 Leser)
Schrift ändern:
(0 Bewertungen)

ACCESSWIRE·Mehr Nachrichten von ACCESSWIRE

IRVINE, CA / ACCESSWIRE / September 15, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Envision Healthcare Corporation ("Envision" or the "Company") (NYSE: EVHC). Investors, who purchased or otherwise acquired shares from March 2, 2015 through July 21, 2017, inclusive (the "Class Period"), are encouraged to contact the Firm before the October 3, 2017 lead plaintiff motion deadline.

If you purchased shares of Envision during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Envision made materially false and/or misleading statements, and/or failed to disclose material information, to investors. On July 24, 2017, The New York Times reported that hospitals associated with the Company's subsidiary, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," in which patients who sought treatment at in-network facilities were treated by out-of-network physicians and then billed at higher rates. When this information went public, Envision's stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP


© 2017 ACCESSWIRE